Microsoft word - classificationsalphaorder.doc

Agents Classified by the IARC Monographs, Volumes 1–102
026148-68-5 A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) 025732-74-5 Acepyrene (3,4-dihydrocyclopenta[cd]pyrene) 3 Acetaldehyde associated with consumption of alcoholic 000103-90-2 Acetaminophen (see Paracetamol) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Acrylonitrile-butadiene-styrene copolymers (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 003688-53-7 AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide] 000097-56-3 ortho-Aminoazotoluene 000150-13-0 para-Aminobenzoic acid 000081-49-2 1-Amino-2,4-dibromoanthraquinone 000082-28-0 1-Amino-2-methylanthraquinone 000712-68-5 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) 000523-50-2 Angelicin plus ultraviolet A radiation (NB: Overall evaluation upgraded to Group 1 based on 000313-67-7 Aristolochic acid, plants containing 007440-38-2 Arsenic and inorganic arsenic compounds Arsenobetaine and other organic arsenic compounds that Art glass, glass containers and pressed ware 001332-21-4 013768-00-8 Asbestos (all forms, including actinolite, amosite, 012172-73-5 anthophyllite, chrysotile, crocidolite, tremolite) (NB: Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) 012174-11-7 Attapulgite (see Palygorskite) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 000202-94-8 11H-Benz[bc]aceanthrylene 3 (NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data) 000211-91-6 Benz[l]aceanthrylene 3 (NB: Overall evaluation upgraded to Group 1 based on 000203-33-8 Benzo[a]fluoranthene 3 000205-99-2 Benzo[b]fluoranthene 2B 000203-12-3 Benzo[ghi]fluoranthene 3 000205-82-3 Benzo[j]fluoranthene 2B 000207-08-9 Benzo[k]fluoranthene 2B (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 1 based on 000105-11-3 para-Benzoquinone dioxime 007440-41-7 Beryllium and beryllium compounds Biomass fuel (primarily wood), indoor emissions from 002168-68-5 Bis(1-aziridinyl)morpholinophosphine sulfide 003296-90-0 2,2-Bis(bromomethyl)propane-1,3-diol 000111-44-4 Bis(2-chloroethyl)ether N,N-Bis(2-chloroethyl)-2-naphthylamine (see 000154-93-8 Bischloroethyl nitrosourea (BCNU) 013483-18-6 1,2-Bis(chloromethoxy)ethane 056894-91-8 1,4-Bis(chloromethoxymethyl)benzene 000542-88-1 Bis(chloromethyl)ether; chloromethyl methyl ether 000108-60-1 Bis(2-chloro-1-methylethyl)ether 002386-90-5 Bis(2,3-epoxycyclopentyl)ether Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) 001675-54-3 Bisphenol A diglycidyl ether (Araldite ) 3 008052-42-4 Bitumens, extracts of steam-refined and air-refined 008052-42-4 Bitumens, steam-refined, cracking-residue and air-refined (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) Boot and shoe manufacture and repair (see Leather dust, 003844-45-9 Brilliant Blue FCF, disodium salt 005589-96-8 Bromochloroacetic acid 000055-98-1 1,4-Butanediol dimethanesulfonate (see Busulfan) 057018-52-7 1-tert-Butoxypropan-2-ol 3 025013-16-5 Butylated hydroxyanisole (BHA) 000128-37-0 Butylated hydroxytoluene (BHT) 007440-43-9 Cadmium and cadmium compounds (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 053973-98-1 Carrageenan, degraded (Poligeenan) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60% 000098-87-3 alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and benzoyl chloride 000106-47-8 para-Chloroaniline 2B 077439-76-0 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone 2B 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea Chloromethyl methyl ether (see Bis(chloromethyl)ether; 000088-73-3 000121-73-3 Chloronitrobenzenes 3 005131-60-2 4-Chloro-meta-phenylenediamine 000095-83-0 4-Chloro-ortho-phenylenediamine 000095-69-2 4-Chloro-ortho-toluidine 2A 000095-79-4 5-Chloro-ortho-toluidine 3 000075-88-7 2-Chloro-1,1,1-trifluoroethane (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 001937-37-7 CI Direct Black 38 (see Benzidine, dyes metabolized to) 002602-46-2 CI Direct Blue 6 (see Benzidine, dyes metabolized to) 016071-86-6 CI Direct Brown 95 (see Benzidine, dyes metabolized to) 059865-13-3 Ciclosporin (see Cyclosporine) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Clonorchis sinensis (infection with) Coal, indoor emissions from household combustion of 008007-45-2 Coal tars (see Coal-tar distillation) 007440-48-4 Cobalt metal with tungsten carbide 012070-12-1 007440-48-4 Cobalt metal without tungsten carbide 010026-24-1 Cobalt sulfate and other soluble cobalt(II) salts 068603-42-9 Coconut oil diethanolamine condensate (NB: There is some evidence of an inverse relationship between coffee drinking and cancer of the large bowel; coffee drinking could not be classified as to its carcinogenicity to other organs) Continuous glass filament (see Glass filament) 000102-50-1 meta-Cresidine 000139-05-9 Cyclamates (sodium cyclamate) 000202-98-2 4H-Cyclopenta[def]chrysene 3 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 007099-43-6 5,6-Cyclopenteno-1,2-benzanthracene 000117-10-2 Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) 000050-29-3 DDT (4,4'-Dichlorodiphenyltrichloroethane) 001163-19-5 Decabromodiphenyl oxide 000083-63-6 Diacetylaminoazotoluene 000613-35-4 N,N'-Diacetylbenzidine 000215-58-7 Dibenz[a,c]anthracene 3 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000224-41-9 Dibenz[a,j]anthracene 3 000194-59-2 7H-Dibenzo[c,g]carbazole 000262-12-4 Dibenzo-para-dioxin 3 005385-75-1 Dibenzo[a,e]fluoranthene 3 000207-83-0 13H-Dibenzo[a,g]fluorene 3 000192-47-2 Dibenzo[h,rst]pentaphene 3 000189-64-0 Dibenzo[a,h]pyrene 2B 000189-55-9 Dibenzo[a,i]pyrene 2B (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000541-73-1 meta-Dichlorobenzene 3 000095-50-1 ortho-Dichlorobenzene 3 000106-46-7 para-Dichlorobenzene 2B 000110-57-6 trans-1,4-Dichlorobutene 028434-86-8 3,3'-Dichloro-4,4'-diaminodiphenyl ether 000075-09-2 Dichloromethane (Methylene chloride) 000609-20-1 2,6-Dichloro-para-phenylenediamine 000542-75-6 1,3-Dichloropropene (technical-grade) 1,2:3,4-Diepoxybutane (see Monographs on 1,3- Diesel engine exhaust (see Engine exhaust, diesel) (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000105-55-5 N,N'-Diethylthiourea 3 000794-93-4 Dihydroxymethylfuratrizine (see also Panfuran S) 000119-90-4 3,3'-Dimethoxybenzidine (ortho-Dianisidine) 000091-93-0 3,3'-Dimethoxybenzidine-4,4'-diisocyanate 000060-11-7 para-Dimethylaminoazobenzene 000140-56-7 para-Dimethylaminoazobenzenediazo sodium sulfonate trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2- 022975-76-4 4,4'-Dimethylangelicin plus ultraviolet A radiation 004063-41-6 4,5'-Dimethylangelicin plus ultraviolet A radiation 000087-62-7 2,6-Dimethylaniline (2,6-Xylidine) 000121-69-7 N,N-Dimethylaniline 3 000119-93-7 3,3'-Dimethylbenzidine (ortho-Tolidine) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000101-25-7 Dinitrosopentamethylenetetramine Dry cleaning (occupational exposures in) Dyes metabolized to benzidine (see Benzidine, dyes Electric fields, extremely low-frequency (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6- 002443-39-2 cis-9,10-Epoxystearic acid Estrogen-progestogen menopausal therapy (combined) Estrogen-progestogen oral contraceptives (combined) (NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary) 000064-17-5 Ethanol in alcoholic beverages (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 1 based on (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 1 based on 033419-42-0 015663-27-1 Etoposide in combination with cisplatin and bleomycin Firefighter (occupational exposure as a) Fission products, including strontium-90 Flat-glass and specialty glass (manufacture of) 016984-48-8 Fluorides (inorganic, used in drinking-water) Foreign bodies (see Surgical implants and other foreign 003570-75-0 2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole Frying, emissions from high-temperature Furniture and cabinet making (see Wood dust) Fusarium graminearum, F. culmorum, and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X) Fusarium moniliforme, toxins derived from (fumonisin B Fusarium sporotrichioides, toxins derived from (T-2 toxin) Gallium arsenide (see Arsenic and inorganic arsenic Gamma-Radiation (see X- and Gamma-Radiation) (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) Gasoline engine exhaust (see Engine exhaust, gasoline) Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3',2'- 067730-10-3 Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Hair colouring products (personal use of) Hairdresser or barber (occupational exposure as a) Helicobacter pylori (infection with) Hepatitis B virus (chronic infection with) Hepatitis C virus (chronic infection with) Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of) Household combustion of coal (see Coal, indoor Human herpesvirus type 4 (see Epstein-Barr virus) Human herpesvirus type 8 (see Kaposi sarcoma Human immunodeficiency virus type 1 (infection with) Human immunodeficiency virus type 2 (infection with) Human papillomavirus genus beta (except types 5 and 8) Human papillomavirus types 5 and 8 (in patients with Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, (NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer) Human papillomavirus types 26, 53, 66, 67, 70, 73, 82 Human papillomavirus types 30, 34, 69, 85, 97 (NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1) Human T-cell lymphotropic virus type II 000193-39-5 Indeno[1,2,3-cd]pyrene 2B (NB: Overall evaluation upgraded to Group 2A) Involuntary smoking (see Tobacco smoke, second-hand) 010043-66-0 Iodine-131 (see Radioiodines) IQ (2-Amino-3-methylimidazo[4,5-f]quinoline) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Iron and steel founding (occupational exposure during) 001338-16-5 Iron sorbitol-citric acid complex 000054-85-3 Isonicotinic acid hydrazide (Isoniazid) Isopropyl alcohol manufacture using strong acids (NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead.) (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Lumber and sawmill industries (including logging) Magnetic fields, extremely low-frequency 000551-74-6 Mannomustine dihydrochloride 068006-83-7 MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) 077094-11-2 MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) 2B 077500-04-0 MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) 2B (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) 007439-97-6 Mercury and inorganic mercury compounds Methoxsalen (8-methoxypsoralen) plus ultraviolet A (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 073459-03-7 5-Methylangelicin plus ultraviolet A radiation 000075-55-8 2-Methylaziridine (Propyleneimine) 001634-04-4 Methyl tert-butyl ether 000099-80-9 N-Methyl-N,4-dinitrosoaniline 4,4'-Methylenebis(2-chloroaniline) (MOCA) (NB: Overall evaluation upgraded to Group 1 based on 000838-88-0 4,4'-Methylene bis(2-methylaniline) 000101-68-8 4,4'-Methylenediphenyl diisocyanate (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000129-15-7 2-Methyl-1-nitroanthraquinone (uncertain purity) N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000615-53-2 N-Methyl-N-nitrosourethane 090456-67-0 N-Methylolacrylamide 3 085878-63-3 7-Methylpyrido[3,4-c]psoralen Michler’s base [4,4′-methylenebis(N,N-dimethyl)- 000090-94-8 Michler’s ketone [4,4′-Bis(dimethylamino)benzophenone] Mineral oils, untreated or mildly treated 000096-24-2 3-Monochloro-1,2-propanediol MOPP and other combined chemotherapy including 5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2- 000505-60-2 Mustard gas (see Sulfur mustard) 003173-72-6 1,5-Naphthalene diisocyanate 111189-32-3 Naphtho[1,2-b]fluoranthene 3 000203-20-3 Naphtho[2,1-a]fluoranthene 3 000193-09-9 Naphtho[2,3-e]pyrene 3 000086-88-4 1-Naphthylthiourea (ANTU) (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) Nitrate or nitrite (ingested) under conditions that result in 000099-59-2 5-Nitro-ortho-anisidine 020268-51-3 7-Nitrobenz[a]anthracene 3 063041-90-7 6-Nitrobenzo[a]pyrene 3 000555-84-0 1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone 000531-82-8 N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide 000126-85-2 Nitrogen mustard N-oxide 037620-20-5 N'-Nitrosoanabasine (NAB) 071267-22-6 N'-Nitrosoanatabine (NAT) 000924-16-3 N-Nitrosodi-n-butylamine 001116-54-7 N-Nitrosodiethanolamine (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000086-30-6 N-Nitrosodiphenylamine 000156-10-5 para-Nitrosodiphenylamine 000621-64-7 N-Nitrosodi-n-propylamine 055557-02-3 N-Nitrosoguvacoline 3 030310-80-6 N-Nitrosohydroxyproline 085502-23-4 3-(N-Nitrosomethylamino)propionaldehyde 3 060153-49-3 3-(N-Nitrosomethylamino)propionitrile 010595-95-6 N-Nitrosomethylethylamine 004549-40-0 N-Nitrosomethylvinylamine 000059-89-2 N-Nitrosomorpholine N'-Nitrosonornicotine (NNN) and 4-(N- Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data) 000100-75-4 N-Nitrosopiperidine 007519-36-0 N-Nitrosoproline 000930-55-2 N-Nitrosopyrrolidine 013256-22-9 N-Nitrososarcosine (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000099-99-0 000099-55-8 5-Nitro-ortho-toluidine 3 Non-arsenical insecticides (occupational exposures in Opisthorchis felineus (infection with) Opisthorchis viverrini (infection with) Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives) 000523-44-4 Orange I (see CI Acid Orange 20) Paint manufacture (occupational exposure in) 012174-11-7 Palygorskite (Attapulgite) (long fibres, > 5 micrometres) 012174-11-7 Palygorskite (Attapulgite)(short fibres, < 5 micrometres) 000794-93-4 Panfuran S (containing dihydroxymethylfuratrizine) Paving and roofing with coal-tar pitch (see Coal-tar pitch) 3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126) (NB: Overall evaluation upgraded to Group 1 based on (NB: Overall evaluation upgraded to Group 1 based on 000087-86-5 Pentachlorophenol (see Polychlorophenols) Petroleum refining (occupational exposures in) Pickled vegetables (traditional in Asia) (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) Phenacetin, analgesic mixtures containing 000136-40-3 Phenazopyridine hydrochloride 000063-92-3 Phenoxybenzamine hydrochloride 000108-45-2 meta-Phenylenediamine 000106-50-3 para-Phenylenediamine 000135-88-6 N-Phenyl-2-naphthylamine 105650-23-5 PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) 2B 053973-98-1 Poligeenan (see Carrageenan, degraded) Polychlorinated dibenzo-para-dioxins (other than 2,3,7,8- Polychlorophenols and their sodium salts (mixed 009016-87-9 Polymethylene polyphenyl isocyanate 023746-34-1 Potassium bis(2-hydroxyethyl)dithiocarbamate Printing processes (occupational exposures in) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 085878-62-2 Pyrido[3,4-c]psoralen 000082-68-8 Quintozene (Pentachloronitrobenzene) Radiofrequency electromagnetic fields1 2B Radionuclides, alpha-particle-emitting, internally (NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents) Radionuclides, beta-particle-emitting, internally deposited (NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents) 013233-32-4 Radium-224 and its decay products 013982-63-3 Radium-226 and its decay products 015262-20-1 Radium-228 and its decay products 010043-92-2 Radon-222 and its decay products 1 Includes radiofrequency electromagnetic fields from wireless phones (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Schistosoma haematobium (infection with) Schistosoma japonicum (infection with) Schistosoma mansoni (infection with) 007782-49-2 Selenium and selenium compounds Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1- Shiftwork that involves circadian disruption 014808-60-7 Silica dust, crystalline, in the form of quartz or cristobalite 000148-18-5 Sodium diethyldithiocarbamate 000132-27-4 Sodium ortho-phenylphenate 2B Soot (as found in occupational exposure of chimney Special-purpose fibres such as E-glass and '475' glass Strong-inorganic-acid mists containing sulfuric acid (see 010098-97-2 Strontium-90 (see Fission products) 009003-54-7 Styrene-acrylonitrile copolymers 009003-55-8 Styrene-butadiene copolymers (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000127-69-5 Sulfafurazole (Sulfisoxazole) (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Sunlamps and sunbeds (see Ultraviolet-emitting tanning Surgical implants and other foreign bodies: - Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid)) - Metallic implants prepared as thin smooth films - Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron Surgical implants and other foreign bodies: - Organic polymeric materials (as a group) - Orthopaedic implants of complex composition - Cardiac pacemakers - Silicone breast implants - Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based and titanium-based alloys, stainless steel and depleted uranium - Dental materials - Ceramic implants 014807-96-6 Talc containing asbestiform fibres (see Asbestos) 014807-96-6 Talc not containing asbestos or asbestiform fibres 014807-96-6 Talc-based body powder (perineal use of) (NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients) (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 008001-50-1 Terpene polychlorinates (Strobane®) 015721-02-5 2,2',5,5'-Tetrachlorobenzidine 001746-01-6 2,3,7,8-Tetrachlorodibenzo-para-dioxin 000127-18-4 Tetrachloroethylene (Perchloroethylene) Tetrakis(hydroxymethyl)phosphonium salts Textile manufacturing industry (work in) 007440-29-1 Thorium-232 and its decay products 008001-35-2 Toxaphene (Polychlorinated camphenes) Toxins derived from certain Fusarium species (see 000817-09-4 Trichlormethine (Trimustine hydrochloride) 001954-28-5 Triethylene glycol diglycidyl ether 090370-29-9 4,4',6-Trimethylangelicin plus ultraviolet A radiation 000068-76-8 Tris(aziridinyl)-para-benzoquinone (Triaziquone) 000545-55-1 Tris(1-aziridinyl)phosphine oxide 000051-18-3 2,4,6-Tris(1-aziridinyl)-s-triazine 000115-96-8 Tris(2-chloroethyl) phosphate 038571-73-2 1,2,3-Tris(chloromethoxy)propane (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000057-39-6 Tris(2-methyl-1-aziridinyl)phosphine oxide 062450-06-0 Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) 062450-07-1 Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole) 012070-12-1 Tungsten carbide with cobalt metal (see Cobalt metal Ultraviolet radiation (wavelengths 100-400 nm, (NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride.) 009003-22-9 Vinyl chloride-vinyl acetate copolymers 000106-87-6 4-Vinylcyclohexene diepoxide (NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride.) 009011-06-7 Vinylidene chloride-vinyl chloride copolymers 000088-12-0 N-Vinyl-2-pyrrolidone (NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders) Wood smoke (see Biomass fuel, indoor emissions from Zeolites other than erionite (clinoptilolite, phillipsite,mordenite, non-fibrous Japanese zeolite,
Last update: 17 June 2011

Source: http://www.ir-ems.ir/files/site1/pages/list.pdf

Microsoft word - e1_2_7

Nur die Originaltexte sind rechtsverbindlich! Verordnung über die Verschreibungspflicht von Arzneimitteln (Arzneimittelverschreibungsverordnung – AMVV) letzte eigearbeitete Änderung: Verordnung vom 19. Februar 2013 (BGBl. I S. 312) Arzneimittel, 1. die in der Anlage 1 zu dieser Verordnung bestimmte Stoffe oder Zubereitungen aus Stoffen 2. die Zubereitungen aus den in der Anlage 1 b

Microsoft word - refractive surgery day review by chris liu.doc

UKISCRS 2008 Refractive Surgery Day 13th November 2009 The Dome, Brighton Report by Christopher Liu FRCOphth Consultant Ophthalmic Surgeon and Honorary Clinical Senior Lecturer, Sussex Eye Hospital, Brighton Medical Director, Tongdean Eye Clinic, Hove Lecture Room 2 was packed with many delegates standing at the back. The day opened with a session chaired by Sheraz Daya and Steve Schallhorn entitl

Copyright © 2008-2018 All About Drugs